Publications by authors named "Walker Busby"

Claim this Profile
O
Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.
Timothy C Nichols, Elizabeth P Merricks, Dwight A Bellinger, Robin A Raymer, Jing Yu, Walker H Busby

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.
Laura A Maile, Katherine Gollahon, Christine Wai, Paul Dunbar, Walker Busby

J Diabetes Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs.
Laura A Maile, Walker H Busby, Katherine A Gollahon, William Flowers, Nikol Garbacik

Endocrinology· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells.
Teresa Cascella, Yashwanth Radhakrishnan, Laura A Maile, Walker H Busby, Katherine Gollahon

Endocrinology· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin lowers glucose production by increasing SOGA.
Rachael B Cowherd, Melissa M Asmar, J McKee Alderman, Elizabeth A Alderman, Alaina L Garland, Walker H Busby

Am J Pathol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Yashwanth Radhakrishnan, Walker H Busby, Xinchun Shen, Laura A Maile, David R Clemmons

J Biol Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of compounds that inhibit IGF-I signaling in hyperglycemia.
Laura A Maile, Lee B Allen, Umadevi Veluvolu, Byron E Capps, Walker H Busby

Exp Diabetes Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigs.
Laura A Maile, Walker H Busby, Timothy C Nichols, Dwight A Bellinger, Elizabeth P Merricks

Sci Transl Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin.
Laura A Maile, Ariel W Aday, Walker H Busby, Ravi Sanghani, Umadevi Veluvolu

J Cell Biochem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.
David R Clemmons, Laura A Maile, Yan Ling, J Yarber, Walker H Busby

Growth Horm IGF Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling.
Laura A Maile, Walker H Busby, Kevin Sitko, Byron E Capps, Tiffany Sergent

Mol Endocrinol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3.
Laura A Maile, Walker H Busby, Kevin Sitko, Byron E Capps, Tiffany Sergent

Mol Endocrinol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Anna M Moralez, Laura A Maile, Jane Clarke, Walker H Busby, David R Clemmons

J Cell Physiol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Tzefu Hsieh, Rebecca E Gordon, David R Clemmons, Walker H Busby, Cunming Duan

J Biol Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
Anna Moralez, Walker H Busby, David Clemmons

Endocrinology· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis.
David R Clemmons, Walker H Busby, Aaron Garmong, Duane R Schultz, David S Howell

Arthritis Rheum· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis